Shanqi Xu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 2
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis 5
- Cancer Cells and Metastasis 4
- Lung Cancer Research Studies 3
- Cytokine Signaling Pathways and Interactions 3
- Cancer Immunotherapy and Biomarkers 2
-
- Ferroptosis and cancer prognosis 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Dabei TangWenhui ZhaoQingyuan ZhangShoubo CaoJin ShiQingwei MengJianxiong GengChunyan Wang
- Partner nations
- ChinaUnited States
In The Last Decade
Shanqi Xu
15 papers receiving 459 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 189
- Oncology 242
- Molecular Biology 218
- Pulmonary and Respiratory Medicine 103
- Immunology and Allergy 17
Countries citing papers authored by Shanqi Xu
This map shows the geographic impact of Shanqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanqi Xu more than expected).
Fields of papers citing papers by Shanqi Xu
This network shows the impact of papers produced by Shanqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanqi Xu. The network helps show where Shanqi Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shanqi Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 17 | |
| 4 | 2021 | 14 | |
| 5 | 2020 | 34 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 27 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 0 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 48 | |
| 12 | 2018 | 34 | |
| 13 | 2013 | 48 | |
| 14 | 2012 | 76 | |
| 15 | 2011 | 8 | |
| 16 | 2011 | 119 |
About Shanqi Xu
Shanqi Xu is a scholar working on Oncology, Toxicology and Cancer Research, having authored 16 papers that have together received 460 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Cancer Cells and Metastasis (4 papers), Lung Cancer Research Studies (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ferroptosis and cancer prognosis (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (189 citations), Oncology (242 citations) and Molecular Biology (218 citations). Shanqi Xu has collaborated with scholars based in China and United States. Frequent co-authors include Dabei Tang, Wenhui Zhao, Qingyuan Zhang, Shoubo Cao, Jin Shi, Qingwei Meng, Jianxiong Geng, Chunyan Wang, Yan Yu and Shu Zhao. Their work appears in journals such as Medical Oncology, Lung, British Journal of Cancer, BioMed Research International and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.